Potassium iodide in successful treatment of erythema nodosum-like lesions induced by combination therapy with dabrafenib and trametinib

J Dermatol. 2020 Jan;47(1):e7-e8. doi: 10.1111/1346-8138.15108. Epub 2019 Oct 6.

Authors

Hiroko Sawada¹, Fuminao Kanehisa¹, Norito Katoh¹, Jun Asai¹

Affiliation

¹ Department of Dermatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan.

PMID: 31587335
DOI: 10.1111/1346-8138.15108

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use
Dermatologic Agents / therapeutic use*
Erythema Nodosum / chemically induced
Erythema Nodosum / drug therapy*
Female
Humans
Imidazoles / adverse effects*
Imidazoles / therapeutic use
Melanoma / drug therapy
Melanoma / genetics
Melanoma / secondary
Middle Aged
Mutation
Oximes / adverse effects*
Oximes / therapeutic use
Potassium Iodide / therapeutic use*
Protein Kinase Inhibitors / adverse effects*
Protein Kinase Inhibitors / therapeutic use
Proto-Oncogene Proteins B-raf / antagonists & inhibitors
Proto-Oncogene Proteins B-raf / genetics
Pyridones / adverse effects*
Pyridones / therapeutic use
Pyrimidinones / adverse effects*
Pyrimidinones / therapeutic use
Skin Neoplasms / drug therapy
Skin Neoplasms / genetics
Skin Neoplasms / pathology

Substances

Antineoplastic Agents
Dermatologic Agents
Imidazoles
Oximes
Protein Kinase Inhibitors
Pyridones
Pyrimidinones
Potassium Iodide
trametinib
BRAF protein, human
Proto-Oncogene Proteins B-raf
dabrafenib